|
|
|
|
| LEADER |
03178nam a22003495i 4500 |
| 001 |
000284823 |
| 005 |
20210524112451.0 |
| 007 |
cr nn 008mamaa |
| 008 |
130125s2013 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781461457114
|
| 024 |
7 |
|
|a 10.1007/978-1-4614-5711-4
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Mesenchymal Stromal Cells :
|b Biology and Clinical Applications /
|c edited by Peiman Hematti, Armand Keating.
|
| 250 |
|
|
|a 1st ed. 2013.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Humana,
|c 2013.
|
| 300 |
|
|
|a XXVI, 695 p. 61 illus., 40 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Stem Cell Biology and Regenerative Medicine,
|
| 505 |
0 |
|
|a MSCs in regenerative medicine: A perspective -- MSCs: Changing hypotheses, paradigms, and controversies on mechanisms of action in repairing tissues -- MSCs: the need to rethink -- Characterization of MSCs: From early studies to the present -- MSCs as therapeutics -- MSC niche for hematopoiesis -- Immunomodulatory properties of MSCs -- MSCs and the innate immune system: A balancing act -- MSCs: paracrine effects -- Cross-talk between MSCs and their environments -- Human MSCs from bone marrow, umbilical cord blood and adipose tissue: all the same? -- MSCs in solid tumors and hematological malignancies: from basic biology to therapeutic potential -- MSC studies in large animal Models -- Defining the potential of MSCs with a prenatal large animal Model -- Bench-to-bedside development of MSC based therapies: A multidisciplinary approach -- GMP production of MSCs -- MSCs: The USA regulatory perspective -- MSCs: Clinical applications and European regulatory aspects -- Stem cell treatments around the world: boon or bane? -- Safety issues in MSC therapy -- In Vivo imaging of MSCs -- National Heart, Lung, and Blood Institute support of cellular therapies regenerative medicine -- MSC therapy of inborn errors -- MSCs for enhancement of hematopoietic progenitor cell engraftment and poor graft function -- MSCs for graft-versus-host disease -- MSCs in paediatric hematopoietic stem cell transplantation -- MSCs for ex vivo expansion of umbilical cord blood cells -- MSCs for autoimmune disorders -- MSCs for induction of solid organ allograft acceptance -- MSCs for gastrointestinal disorders -- MSCs for cardiac repair -- MSCs for acute lung injury -- MSCs for diabetes -- MSCs for renal repair -- MSCs for the treatment of stroke, spinal cord injury, and traumatic brain injury: From bench work to clinical trials -- MSCs in reconstructive surgery -- MSCs in orthopedic surgery -- Adipose tissue derived MSCs: Moving to the clinic.
|
| 650 |
|
0 |
|a Stem cells.
|
| 650 |
|
0 |
|a Cell biology.
|
| 650 |
|
0 |
|a Biotechnology.
|
| 650 |
1 |
4 |
|a Stem Cells.
|
| 650 |
2 |
4 |
|a Cell Biology.
|
| 650 |
2 |
4 |
|a Biotechnology.
|
| 700 |
1 |
|
|a Hematti, Peiman.
|e editor.
|
| 700 |
1 |
|
|a Keating, Armand.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|